Immune Checkpoint Inhibition in EGFR–Mutant Metastatic Lung Cancer: Has the Sun Set?

2021 ◽  
Keyword(s):  
Lung Cancer ◽  
Immune Checkpoint ◽  
The Sun ◽  
Metastatic Lung Cancer ◽  
Checkpoint Inhibition ◽  
Immune Checkpoint Inhibition ◽  
Metastatic Lung ◽  
Egfr Mutant

scholarly journals Use of Curcumine with Tyrosine Kinase Inhibitors in EGFR-mutant Non-Small Cell Lung Cancer. A Phase I prospective Cohort Trial

2021 ◽  
Vol 7 (5) ◽  
pp. 1-8
Author(s):  
Goulnar Kasymjanova ◽  
Keyword(s):  
Lung Cancer ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Prospective Clinical Study ◽  
Metastatic Lung Cancer ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Metastatic Lung ◽  
Egfr Mutant ◽  
Egfr Tkis

Our study is the first prospective clinical study using combination of curcumin and EGFR-TKIs in metastatic lung cancer patients. The future randomized larger-scale clinical trials using this combination is feasible and safe. RCT will seek to assess the potential effects on survival and response to TKIs

Sign in / Sign up

Export Citation Format

Share Document